Aspirin does not improve the survival rate of COVID-19 hospitalized patients

According to the British Rehabilitation Trial, aspirin cannot improve the survival rate of covid-19 hospitalized patients
.

Aspirin does not improve the survival rate of covid-19 hospitalized patients
.

Aspirin does not improve the survival rate of covid-19 hospitalized patients

COVID-19 blood vessels

The trial is testing a range of possible treatments for covid-19 hospitalized patients
.

7351 patients were randomized to take 150 mg aspirin once a day, and 7541 patients were randomized to receive conventional treatment.

There is no evidence that aspirin therapy reduced the mortality rate is no evidence that aspirin therapy reduced the mortality rate of thrombosis

Data shows that in patients hospitalized with covid-19, aspirin has nothing to do with reducing the 28-day mortality rate or the risk of progression to invasive mechanical ventilation or death
.

Although aspirin can slightly increase the likelihood of survival and discharge, it does not seem to be enough to prove that it can be widely used in covid-19 patients

In patients hospitalized with covid-19, aspirin is not associated with reducing the 28-day mortality or the risk of progression to invasive mechanical ventilation or death .

Anthony Gordon, professor of anesthesiology and critical care at Imperial College London and NIHR research professor, said the findings were "disappointing" but "knowing these are important" and "the important thing is that there is no major safety The problem, therefore, the Remap-Cap trial continues to evaluate aspirin and other similar drugs to prevent blood clots, combined with other treatments for the most severe covid-19 patients in intensive care
.

"

prevention

The results of this aspirin evaluation were published on medRxiv on June 8, 2021, and have been submitted to a leading peer-reviewed medical journal

Original source

Recovery trial finds aspirin does not improve survival for patients hospitalised with covid-19.

Recovery trial finds aspirin does not improve survival for patients hospitalised with covid-19.
8 June 2021.
Recovery trial finds aspirin does not improve survival for patients hospitalised with covid-19.
8 June 2021.
Leave a message here